| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Sphingolipid metabolism overview 0.8831772343632414 2.5784354173812685 0.0099248850144741 0.9977219230969324 1.0 8 O15121,Q13510,O15269,O95470,Q96G23,Q06136 6 |
| Sphingolipid metabolism integrated pathway 0.8861496719751786 2.5699099195847026 0.0101724962496572 0.9980442855391932 1.0 9 O15121,Q13510,O15269,P27544,O95470,Q96G23,Q06136 7 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8334858775919904 2.402753863934884 0.0162721357329169 0.9999549459797996 1.0 6 Q15392,Q16850,O75845,Q14739 4 |
| Glycerophospholipid biosynthetic pathway 0.8269601100412587 2.329867648840987 0.0198131473489635 0.9999950064141953 1.0 8 O14735,P48651,O15228,Q8WUK0,Q9BTU6,Q9HCL2,Q9Y6K0 7 |
| Oxidation by cytochrome p450 0.8165347412055647 2.326742419680879 0.0199789786762285 0.9999954961001468 1.0 6 O43169,Q6UW02 2 |
| Striated muscle contraction pathway 0.7893373754433388 2.181380947775522 0.0291552516245234 0.9999999854999572 1.0 7 Q8WZ42,P09493,P08670 3 |
| Proteoglycan biosynthesis 0.7835646613493168 2.1549673277496497 0.0311643910211356 0.9999999959021456 1.0 7 Q8TB61,Q9NX62,Q8NCH0 3 |
| Glycosaminoglycan degradation 0.7755190320863659 2.140066114615472 0.0323494240625208 0.999999998057678 1.0 6 P15586,P08236,P16278,P54802 4 |
| Sphingolipid pathway 0.7896492477003372 2.1175450412042056 0.0342136168833155 0.9999999994009576 1.0 10 P04062,Q13510,O15269,O95470,Q96G23,Q06136 6 |
| Omega3 omega6 fatty acid synthesis 0.7654830397967785 2.0937984788265234 0.0362779357433467 0.999999999837595 1.0 6 O95864,O15254 2 |
| Vitamin d metabolism 0.8286855748981778 1.9888313928675412 0.0467198164675046 0.9999999999997888 1.0 4 P38435,P04062 2 |
| Mitochondrial complex iii assembly 0.7530251736524259 1.970236171114789 0.0488113098568556 0.9999999999999448 1.0 9 Q9UDW1,O14949 2 |
| Triacylglyceride synthesis 0.7902981758221908 1.94304366792462 0.0520108823831009 0.9999999999999928 1.0 5 O15228,Q9NUQ2,Q9HCL2 3 |
| Tyrobp causal network in microglia 0.7171751517931768 1.8679254272371937 0.0617724661023544 1.0 1.0 6 Q15418,P61916,O15439 3 |
| 15q112 copy number variation syndrome 0.7726772952171429 1.8653944793230368 0.0621261306297327 1.0 1.0 5 Q96RT8,Q06787,Q9BSJ2,Q7L576 4 |
| Degradation pathway of sphingolipids including diseases 0.7039034579413334 1.8049852837366545 0.071076984918031 1.0 1.0 6 O43681,P17900,P16278,P06865 4 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7567339050402511 1.7946684696048956 0.0727065370148527 1.0 1.0 5 P49354,Q03252,O60725 3 |
| Sphingolipid metabolism in senescence 0.7174708441325133 1.6965489611186415 0.0897819661565026 1.0 1.0 14 O15121,P04062,Q13510,P16278,O15269,Q96G23,Q06136 7 |
| Glucocorticoid receptor pathway 0.6795726973041774 1.6886726834304826 0.0912821732901534 1.0 1.0 6 Q86UP2,P27105 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7467890293642694 1.6346036519973015 0.1021321615903776 1.0 1.0 4 Q07820 1 |
| Mitochondrial complex iv assembly 0.6931811268005807 1.581438412551169 0.1137778303458012 1.0 1.0 14 P13073,P00403,Q9Y6N1,P14406,Q9Y2R0,P20674,O43819,P09669 8 |
| Vitamin a and carotenoid metabolism 0.7001658218604063 1.5405012537864713 0.1234382174212305 1.0 1.0 5 Q8WTV0 1 |
| Kennedy pathway from sphingolipids 0.6356731854241131 1.4761164802248217 0.1399126254512612 1.0 1.0 6 O95470,Q9Y6K0,P48651 3 |
| Glycerolipids and glycerophospholipids 0.6217830887271352 1.408264831475123 0.159052665292438 1.0 1.0 6 O14735,P48651,Q9HCL2 3 |
| Mitochondrial immune response to sarscov2 0.6333952241281984 1.378623359226281 0.1680109105481122 1.0 1.0 10 Q9Y6M9 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.8195054945054951 1.3763432569401044 0.1687153865685382 1.0 1.0 3 O95470,Q06136 2 |
| Ccl18 signaling pathway 0.6339970391184038 1.3603474285053307 0.1737200062617701 1.0 1.0 11 Q96GC9,P08670,P07196,Q86UE4 4 |
| Aryl hydrocarbon receptor pathway wp2873 0.6070191356138009 1.3359083543542791 0.1815792299542742 1.0 1.0 6 P10620,Q16543 2 |
| Glycosylation and related congenital defects 0.6065702090208217 1.2481840478924786 0.2119636644198594 1.0 1.0 10 Q9BT22,Q9H3H5,Q9H0U3,Q9H6U8,Q2TAA5 5 |
| Influence of laminopathies on wnt signaling 0.6145415657172407 1.2450966731788973 0.2130962168754477 1.0 1.0 12 P50402,O75844,O60725 3 |
| 1q211 copy number variation syndrome 0.5985384700008223 1.2300977050611934 0.2186605193538779 1.0 1.0 9 Q9NPH0 1 |
| Familial partial lipodystrophy fpld 0.5920673798261022 1.219634296458684 0.2226035390316503 1.0 1.0 8 P49354,Q03252,O75844,O60725 4 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.5865718115477314 1.213980906429652 0.2247550153975506 1.0 1.0 7 P09601,P07099 2 |
| Omega9 fatty acid synthesis 0.5759107514571068 1.182951106452732 0.236828525417412 1.0 1.0 6 O95864,O00767 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6151815455740658 1.1463484968579565 0.2516509839338869 1.0 1.0 17 O60725,P42167,P50402,P55209,O75844 5 |
| Copper homeostasis 0.5852126458809995 1.144141566425608 0.2525649317754785 1.0 1.0 10 P05067,O75880,Q9Y6N1,O43819 4 |
| Amyotrophic lateral sclerosis als 0.584262494741245 1.1395137419618395 0.2544889399518788 1.0 1.0 10 P07197,P07196,Q9BUN8 3 |
| Inclusion body myositis 0.7599839367957952 1.117766286387634 0.2636668238689461 1.0 1.0 3 P05067 1 |
| Allograft rejection 0.5781216506050068 1.0890186720561157 0.2761456517328144 1.0 1.0 11 Q9BY49,P04439,P10321,P49327,P08670 5 |
| Disruption of postsynaptic signaling by cnv 0.5595753659013363 1.0606256841500694 0.2888600454311749 1.0 1.0 8 Q07157,Q06787,Q14168,Q7L576 4 |
| Insulin signaling in adipocytes normal condition 0.6168153052376835 1.0599200088879035 0.2891809919683719 1.0 1.0 4 P42345 1 |
| Insulin signaling in adipocytes diabetic condition 0.6168153052376835 1.0599200088879035 0.2891809919683719 1.0 1.0 4 P42345 1 |
| Urea cycle and related diseases 0.7926393847843951 0.9690140643636505 0.3325381719691078 1.0 1.0 2 Q9Y619 1 |
| Liver x receptor pathway 0.7909914858555329 0.9618103969323238 0.3361448544686323 1.0 1.0 2 O00767 1 |
| Estrogen receptor pathway 0.7229478533109213 0.9594160683022048 0.3373491835195858 1.0 1.0 3 Q9HCL2 1 |
| Drug induction of bile acid pathway 0.7860477890689357 0.9402587565435556 0.3470848495677887 1.0 1.0 2 O15439 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.7860477890689346 0.9402587565435514 0.3470848495677909 1.0 1.0 2 P28288 1 |
| Cholesterol biosynthesis pathway 0.5539803821243616 0.9127638067495556 0.3613667774543661 1.0 1.0 14 P04035,P37268,Q15800,O75845,Q16850,Q14534 6 |
| Caloric restriction and aging 0.5664376618508944 0.840294337215624 0.4007433756896308 1.0 1.0 4 P43490 1 |
| Endothelin pathways 0.5223508977597722 0.8401105695770738 0.4008463944067362 1.0 1.0 10 P42892,P16615 2 |
| Oxidative stress response 0.513574093068796 0.8375140682526367 0.4023036725426552 1.0 1.0 8 P09601 1 |
| Preimplantation embryo 0.5109445508488932 0.8249123948747539 0.4094213288217618 1.0 1.0 8 P05023,Q92945 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5707658896648559 0.8041441390174047 0.4213137355981167 1.0 1.0 24 Q15392,P35610,P04035,P37268,Q14739,Q15800,O95864,Q16850,Q14534 9 |
| Progeriaassociated lipodystrophy 0.5169551099509406 0.7759491403555446 0.4377790162646038 1.0 1.0 12 P49354,Q03252,O75844,O60725 4 |
| Sarscov2 and covid19 pathway 0.5311366941927949 0.6912553878302898 0.4894050620310226 1.0 1.0 4 P35610 1 |
| Nanoparticle triggered autophagic cell death 0.4774899378372473 0.6858402263202292 0.4928138666216606 1.0 1.0 7 Q96GC9,Q9Y371 2 |
| Statin inhibition of cholesterol production 0.4731074455315003 0.6843166561825587 0.4937752314733263 1.0 1.0 6 P35610,P04035,P37268,Q14534 4 |
| Bdnftrkb signaling 0.486985591403078 0.6737766845270671 0.5004533000902309 1.0 1.0 10 Q15418,P42345,P49815 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6340659340659354 0.5997167035128019 0.5486950542635691 1.0 1.0 3 Q15758,Q14145 2 |
| Cytosine methylation 0.4878386847143892 0.5865231308472164 0.5575240221409348 1.0 1.0 5 P48735 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.4741024162844891 0.5791812642151298 0.5624668714203986 1.0 1.0 12 P16615,P12814,O43707,P50402,P02545 5 |
| Pregnane x receptor pathway 0.4457647627319322 0.5586210040368124 0.5764204022088419 1.0 1.0 6 O15439,P07900 2 |
| Serotonin and anxiety 0.6923921999450662 0.5564883038450272 0.5778770879183381 1.0 1.0 2 Q06787 1 |
| Ferroptosis 0.5105443772589527 0.536300229477255 0.5917510720402204 1.0 1.0 24 Q9Y277,P37268,P09601,Q15043,P45880 5 |
| Erk pathway in huntingtons disease 0.4689389774601256 0.5090015679189167 0.6107511250967477 1.0 1.0 5 P28482,P42574,P42858,O14733 4 |
| Monoamine transport 0.4659000490543817 0.4361925923182883 0.6626970020464358 1.0 1.0 4 O15127 1 |
| Cohesin complex cornelia de lange syndrome 0.4635059592006333 0.4345445471136802 0.6638930533146152 1.0 1.0 18 P06493,Q15257,Q29RF7,Q96GD4,Q8N3U4,Q9UQE7,Q7Z5K2,Q14674,P30154,P53350,Q9Y6X3,P30153 12 |
| Vitamin d receptor pathway 0.4369235303206479 0.4193321218783485 0.6749734239924088 1.0 1.0 12 Q92604,Q5VV42,P09493,P08183,Q96KA5,P20020 6 |
| Proximal tubule transport 0.4363309866103675 0.4168954251158276 0.6767548999594386 1.0 1.0 12 Q9Y5K8,P04920,P08183,O15439,P05023 5 |
| Camkk2 pathway 0.4423364918965006 0.4101826499205774 0.6816719672790803 1.0 1.0 14 P09601 1 |
| Wntbetacatenin signaling pathway in leukemia 0.4586424841989767 0.4101582215119672 0.6816898858112947 1.0 1.0 4 P48729,P49841,P35222 3 |
| 7oxoc and 7betahc pathways 0.4178459290807701 0.3884389309738685 0.697691238792967 1.0 1.0 9 P61916,O15118 2 |
| Nephrogenesis 0.6322438890414666 0.3492112148453575 0.726930747338755 1.0 1.0 2 Q04721 1 |
| Mitochondrial complex i assembly model oxphos system 0.4781111509105406 0.345779817645609 0.7295081938233983 1.0 1.0 28 Q9Y6M9,Q9NX14,Q9NPL8,O96000,P03886,Q9P0J0,O95168,P17568,P51970,O75438,O43676,Q8IUX1,Q96CU9 13 |
| Thiamine metabolic pathways 0.3847853526821692 0.3036216098659424 0.7614161860535893 1.0 1.0 6 P12694,Q9HC21 2 |
| Osx and mirnas in tooth development 0.6163141993957643 0.301691295050717 0.7628874048177152 1.0 1.0 2 Q04721 1 |
| Metapathway biotransformation phase i and ii 0.4436544139893258 0.2996046940896232 0.7644787032096139 1.0 1.0 22 P10620,P07099,Q8NCH0,P21964,Q7LGA3,Q6UW02,Q99735,Q16850 8 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.4119768994406071 0.2966990839411216 0.7666962564731543 1.0 1.0 5 Q07820,P42574 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3862139978022985 0.2946707534459636 0.7682454070160383 1.0 1.0 7 P42345 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.5435388966097451 0.2943739678403591 0.768472156756643 1.0 1.0 3 P48729 1 |
| Adipogenesis 0.4199582352005521 0.2942312329938833 0.7685812158989322 1.0 1.0 16 O14654,O00767,P43490,P14174,P49327,O75844 6 |
| Leukocyteintrinsic hippo pathway functions 0.3878195990111557 0.2726842132014487 0.7850959710180261 1.0 1.0 9 Q96GC9 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3908476130824793 0.2434772245848683 0.807635726483027 1.0 1.0 12 Q32P28,O75718,P13674 3 |
| Vitamin dsensitive calcium signaling in depression 0.368709764366385 0.2187731190480955 0.8268267875359183 1.0 1.0 8 Q8NB78,Q14571,P20020,P11413,P23634 5 |
| Neuroinflammation 0.3576851415566271 0.2068869112444225 0.8360981786953114 1.0 1.0 6 P00403 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3932972342733387 0.2019498956252505 0.8399558945288121 1.0 1.0 16 P08670 1 |
| Ovarian infertility 0.5065137931028078 0.1980034109409468 0.8430423950223662 1.0 1.0 3 Q8WXH0 1 |
| Interactions between loxl4 and oxidative stress pathway 0.3889802960260806 0.1947867946448739 0.8455598606244168 1.0 1.0 4 Q8TAG9,Q16543 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3772863242579541 0.1860334717591941 0.8524185128084938 1.0 1.0 13 P49815,P42345,P54646 3 |
| Spinal cord injury 0.4003304984718938 0.17788342737797 0.8588145263071867 1.0 1.0 20 Q9NQC3 1 |
| Electron transport chain oxphos system in mitochondria 0.5222273852462808 0.175519899487076 0.8606711359555985 1.0 1.0 55 P12236,P14406,P17568,P05141,Q9UDW1,O43676,O14949,P09669,O95168,P12235,P51970,P13073,O75880,Q9Y6N1,O14548,P06576,P24539,O75438,P22695,Q9Y6M9,P00403,O96000,P03886,P56385,O75964 25 |
| Photodynamic therapyinduced ap1 survival signaling 0.3591509890479892 0.1755025297331431 0.8606847831910223 1.0 1.0 9 Q07820,P07900 2 |
| Hippoyap signaling pathway 0.3690748118575003 0.1660266312956055 0.868135992275918 1.0 1.0 5 Q13043 1 |
| Genes related to primary cilium development based on crispr 0.3775152311724104 0.1639358504764823 0.8697816442773163 1.0 1.0 15 Q10713,Q8NCM8,A0AVF1,Q92845,O95684 5 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3588622732898341 0.1520638014266518 0.8791366144067516 1.0 1.0 11 Q8TB36,P50570,P07196,O95140 4 |
| Nephrotic syndrome 0.3672896908094997 0.1339179470887456 0.8934674583949929 1.0 1.0 15 Q9BT22,Q14108,P11047,O43707,P35579,O75844 6 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.3341584158415938 0.1233797067022299 0.9018064259910832 1.0 1.0 7 P28482,P18206,P27361,Q07157,P12814,P19174 6 |
| Interleukin1 induced activation of nfkb 0.4695054945054962 0.1219088614867365 0.9029711975260256 1.0 1.0 3 P51617,P61088 2 |
| Ethanol effects on histone modifications 0.3480241601142976 0.1209967639584821 0.9036935983506268 1.0 1.0 11 P00374,P04818,Q9H9T3,Q96KQ7,P05091 5 |
| Oxidative phosphorylation 0.422787572183827 0.1182291989742967 0.90588605476714 1.0 1.0 32 Q9Y6M9,O96000,P03886,O95168,P06576,P17568,Q86Y39,P24539,P56385,O75438,Q15904,O75964 12 |
| Glycogen synthesis and degradation 0.3715722306248823 0.10584163795173 0.915708000004525 1.0 1.0 19 P52789,P0DP25,P46020,P30154 4 |
| Gastric cancer network 2 0.3596899679200999 0.1032458790147816 0.917767828255613 1.0 1.0 16 Q9HB71,Q86UE4,Q14739 3 |
| Sulfation biotransformation reaction 0.3446001648804812 0.0974391819345962 0.9223776300681767 1.0 1.0 4 O43252,P11413,O95340 3 |
| Constitutive androstane receptor pathway 0.3179009140740058 0.0808552005262461 0.9355571080596632 1.0 1.0 7 P08183,P07900 2 |
| Nanoparticle triggered regulated necrosis 0.5042570722328937 0.0741778574073009 0.9408688645322052 1.0 1.0 2 Q13546 1 |
| Hair follicle development organogenesis part 2 of 3 0.4343406593406611 0.0687470854090565 0.9451909380970724 1.0 1.0 3 Q9BZE4,P35222 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3159578636644246 0.0591085390113061 0.9528656573879988 1.0 1.0 9 P61020,P27361,P31943,P20339 4 |
| Myd88 distinct inputoutput pathway 0.4817357868717318 0.0507166627338508 0.9595512987946442 1.0 1.0 2 P61088 1 |
| Ltf danger signal response pathway 0.4817357868717287 0.050716662733848 0.9595512987946464 1.0 1.0 2 P28482 1 |
| Nocgmppkg mediated neuroprotection 0.3038526618145561 0.0487184322453966 0.9611436865095582 1.0 1.0 7 P07196 1 |
| Mthfr deficiency 0.3135415899711627 0.0458638217756269 0.9634187898576978 1.0 1.0 10 P21964,Q7L592,P56192 3 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3055157565436071 0.0444529465751895 0.9645433580648471 1.0 1.0 8 Q8NE86 1 |
| Tryptophan metabolism 0.32717231703098 0.0436964728622172 0.9651463507813856 1.0 1.0 14 Q15392,P51648 2 |
| P53 transcriptional gene network 0.3112443884040419 0.0410710413624441 0.9672392607616556 1.0 1.0 10 P49327,P04066,P11166 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3475285751469414 0.0405473427255445 0.9676567640160948 1.0 1.0 20 Q8WXH0,P33176,P42167,Q14739,P50402,O94901 6 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.3039258750277357 0.0337177764860584 0.9731022034460924 1.0 1.0 9 P51812 1 |
| Nonalcoholic fatty liver disease 0.4697087512664767 0.0239828438563606 0.9808662933911328 1.0 1.0 57 P14406,Q9P0J0,P17568,Q9UDW1,O43676,O14949,Q96GC9,P09669,O95168,P51970,P13073,O14548,Q96J02,O75438,P22695,Q9Y6M9,Q9NX14,P00403,O96000,Q86Y39 20 |
| Pkcgamma calcium signaling pathway in ataxia 0.4424608624004328 0.0238097027309892 0.9810044005842996 1.0 1.0 2 P23634 1 |
| Ptf1a related regulatory pathway 0.4213128261466566 0.0151064872666984 0.9879472254628388 1.0 1.0 2 P35222 1 |
| Pathogenic escherichia coli infection 0.3562570894596692 0.0148925122751747 0.9881179336001832 1.0 1.0 26 Q16625,P68371,Q13885,P04350,P07437,Q9BVA1 6 |
|
|
